Literature DB >> 10740973

Fertilization failure and oocyte activation.

S Yamano1, K Nakagawa, H Nakasaka, T Aono.   

Abstract

Recent reports have suggested that when unfertilized oocytes with a spermatozoon after intracytoplasmic sperm injection (ICSI) are properly activated, the activated oocytes develop normally similar to fertilized oocytes. However, human oocytes do not easily respond to universal activators of mammalian oocytes like ethanol or calcium ionophore A23187, which induce a calcium transient in ooplasm. Puromycin activates human oocytes at a rate of 90%, but more than two thirds of the parthenogenesis possess 2 haploid pronuclei or 1 diploid pronucleus without extrusion of the second polar body. Therefore, the activation method which produces one pronucleus with extrusion of the second polar body in oocytes without a spermatozoon is necessary for producing embryos with normal karyotypes. Recently, we found the oocyte activation method which produced parthenogenesis displaying one pronucleus with extrusion of the second polar body. Using our method (a combination of calcium ionophore A23187 and puromycin), the activation rate was approximately 90% and the proportion of parthenogenesis displaying one pronucleus with extrusion of the second polar body was approximately 80% in human aged and mouse young oocytes. When human unfertilized oocytes following ICSI were activated by this method, two pronuclei were formed with extrusion of the second polar body in 30% of the oocytes. Four cleaved parthenogenesis (or embryos) showed normal karyotypes. However, the cytotoxic, teratogenetic and mutagenetic activity of Ca ionophore and puromycin should be approved prior to the clinical adaptation of the method.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10740973

Source DB:  PubMed          Journal:  J Med Invest        ISSN: 1343-1420


  11 in total

Review 1.  Parthenotes as a source of embryonic stem cells.

Authors:  T A L Brevini; F Gandolfi
Journal:  Cell Prolif       Date:  2008-02       Impact factor: 6.831

Review 2.  Understanding fertilization through intracytoplasmic sperm injection (ICSI).

Authors:  Queenie V Neri; Bora Lee; Zev Rosenwaks; Khaled Machaca; Gianpiero D Palermo
Journal:  Cell Calcium       Date:  2013-11-15       Impact factor: 6.817

Review 3.  Parthenogenesis as an approach to pluripotency: advantages and limitations involved.

Authors:  Tiziana A L Brevini; Georgia Pennarossa; Stefania Antonini; Fulvio Gandolfi
Journal:  Stem Cell Rev       Date:  2008-06-12       Impact factor: 5.739

Review 4.  The present status of artificial oocyte activation in assisted reproductive technology.

Authors:  Kaoru Yanagida; Yoko Fujikura; Haruo Katayose
Journal:  Reprod Med Biol       Date:  2008-08-03

Review 5.  The status of human nuclear transfer.

Authors:  Vanessa J Hall; Miodrag Stojkovic
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

6.  The effects of ex vivo cold-storage on cryopreservation of the goat (Caprus hircus) epididymal sperm.

Authors:  Seyed Kamal-Aldin Hoseinzadeh-Sani; Farid Barati; Mahmoud Khaksary Mahabady
Journal:  Iran J Reprod Med       Date:  2013-09

7.  Effect of caffeine on motility and vitality of sperm and in vitro fertilization of outbreed mouse in T6 and M16 media.

Authors:  Narges Nabavi; Fatemeh Todehdehghan; Abdollhossein Shiravi
Journal:  Iran J Reprod Med       Date:  2013-09

8.  Effect of oocyte activation with calcium ionophore on ICSI outcomes in teratospermia: A randomized clinical trial.

Authors:  Maryam Eftekhar; Sima Janati; Mozhgan Rahsepar; Abbas Aflatoonian
Journal:  Iran J Reprod Med       Date:  2013-11

9.  Facilitating and inhibiting factors related to treatment adherence in women with polycystic ovary syndrome: A qualitative study.

Authors:  Fatemeh Bazarganipour; Seyed Abdolvahab Taghavi; Helen Allan; Nazafarin Hosseini
Journal:  Int J Reprod Biomed       Date:  2017-09

10.  Effect of calcium ionophore on unfertilized oocytes after ICSI cycles.

Authors:  Maryam Eftekhar; Farnaz Mohammadian; Fariba Yousefnejad; Parisa Khani; Abbas Aflatoonian
Journal:  Iran J Reprod Med       Date:  2012-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.